Genetix gets $35m infusion for gene therapy work - Boston Globe
Genetix gets $35m infusion for gene therapy work Boston Globe Genetix Pharmaceuticals, a 17-year-old developer of gene therapies, has replenished its coffers with a $35 million Series B round of venture capital. ...
Do angels deserve a tax break? - Minneapolis Star Tribune
Do angels deserve a tax break? Minneapolis Star Tribune Do you really need venture capital (VC) to create ventures? In the 1970s, Minnesota was one of the top VC centers in the country. ...